Filing metadata

Accession number
0001104659-21-054973
Form type
Form 3
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Apr 26, 2021
Reporting period
Apr 22, 2021
Description
Initial ownership

Explore SEC Filings Hub